Research suggests that cold therapy applied to the head or neck may offer modest short-term relief for some migraine sufferers, with a 2023 systematic review and meta-analysis of six clinical trials finding meaningful pain reduction at 30 minutes post-treatment, though benefits at 24 hours were not statistically significant and the overall evidence quality was rated as very low to moderate. Supporting this, older and smaller studies indicate that cold wraps, ice packs, and similar methods provide at least partial relief for a portion of patients — roughly two-thirds in one 1989 study — while a 2016 review points to the TRPM8 cold-sensing ion channel as a plausible biological mechanism through which cold stimulation may modulate migraine pain signaling. However, the body of evidence is limited by small sample sizes, methodological variability, and inconsistent outcomes; notably, a 2024 feasibility trial of intranasal cooling was discontinued after participants reported significant discomfort and minimal benefit. Studies indicate that cold therapy is unlikely to be universally effective — some individuals may find no relief, and cold can even trigger migraines in certain people — so the research, while generally supportive in direction, warrants cautious interpretation pending larger and more rigorous trials.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Cold intervention for relieving migraine symptoms: A systematic review and me... | Meta-analysis | 2023 | Supports | 97 |
| Cryotherapy for headache. | Other | 1989 | Supports | 92 |
| Head cooling for exercise-induced headache. | Other | 2006 | Supports | 90 |
| A Feasibility Trial on Intranasal Evaporative Cooling for Acute Migraine in a... | Other | 2024 | Supports | 88 |
| Head band for migraine headache relief. | Other | 1993 | Supports | 72 |
| TRPM8 and Migraine. | Review | 2016 | Supports | 65 |
| Management of local and delayed cutaneous hypersensitivity reactions to anti-... | Other | 2025 | Neutral | 58 |